跳至主要内容
临床试验/NCT02584868
NCT02584868已完成3 期

Colloids in Pediatric Cardiac Surgery: Comparison Between a Balanced and a Non-balanced Colloid

Queen Fabiola Children's University Hospital1 个研究点 分布在 1 个国家目标入组 88 人开始时间: 2013年2月15日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
88
试验地点
1
主要终点
Calculated Blood Loss at 3rd Post Operative Day (POD)

研究概览

简要总结

This study will compare the clinical efficacy and safety of Volulyte® and Voluven® during elective open-heart surgery in pediatric patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
28 Days 至 3 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Age 28 days to 3 years old
  • Planned cardiac surgery with cardiopulmonary by-pass
  • signed informed consent

排除标准

  • Moribund patients (ASA 5)
  • Jehovah Witnesses
  • Pre-operative coagulation disorders
  • Pre-operative renal insufficiency
  • Pre-operative hepatic disorders
  • Intra-cranial hemorrhage
  • hypernatremia

研究组 & 干预措施

Volulyte

Experimental

Investigational drug: HES 130/0.4 (6%) in an isotonic electrolyte solution (brand name=Volulyte®)

干预措施: Hydroxyethyl starch 130/0.4 in an isotonic electrolyte solution (Drug)

Voluven

Active Comparator

Control drug: HES 130/0.4 (6%) in sodium chloride 0.9% (brand name=Voluven®)

干预措施: Hydroxyethyl starch 130/0.4 in 0.9% sodium chloride (Drug)

结局指标

主要结局

Calculated Blood Loss at 3rd Post Operative Day (POD)

时间窗: 72H post surgery

次要结局

  • Creatinine(Post-operative Day 3)
  • Total Blood Loss(72H post surgery)
  • Exposure to Any Blood Products(72H post surgery)
  • Exposure to Red Blood Cell(72H post surgery)
  • Red Blood Cell Transfused(72H post surgery)
  • Intraoperative Blood Loss(End of surgery, an average of 200 minutes)
  • Fresh Frozen Plasma Transfused(72H post surgery)
  • Clotting Time in Seconds(End of surgery, an average of 200 minutes)
  • Maximal Cloth Firmness(End of surgery, an average of 200 minutes)
  • Chest Tube Drainage(72H post surgery)
  • Exposure to Fresh Frozen Plasma(72H post surgery)
  • Exposure to Platelets(72H post surgery)
  • Platelet Transfused(72H post surgery)
  • C-Reactive Protein (CRP)(At admission to the pediatric intensive care unit (Hour 0 Day 0 after surgery))
  • PTT(Post-operative Day 2)
  • APTT(Post-operative Day 2)
  • INR(Post-operative Day 2)
  • Fibrinogen(Post-operative Day 2)
  • CRP(Post-operative Day 3)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验